Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Colleague Insights
Grand Rounds
Conferences
Video Expert Opinion
Living Resources
Sign in
Join now
Peter Lin MD, CCFP
Peter Lin MD, CCFP Associate Editor
Nekesha Oliphant MD
Nekesha Oliphant MD Advisory Board
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
See All Experts
featured
Published in Primary Care and
3 other channels

Journal Scan / Research · November 05, 2020

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes

JAMA Cardiology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

JAMA Cardiology
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-Analysis
JAMA Cardiol 2020 Oct 07;[EPub Ahead of Print], DK McGuire, WJ Shih, F Cosentino, B Charbonnel, DZI Cherney, S Dagogo-Jack, R Pratley, M Greenberg, S Wang, S Huyck, I Gantz, SG Terra, U Masiukiewicz, CP Cannon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated